What You Should Know:
– Ryght AI, a leading AI clinical trial developer, today announced a partnership with Biorasi, a global clinical research organization (CRO) specializing in dermatology, oncology, neurology, and nephrology studies.
– The collaboration will bring advanced,…
Continue Reading
The emergence of SARS-CoV-2 (COVID-19) has demonstrated the severe impact of infectious diseases on global society, politics, and economies. To mitigate future pandemics, preemptive measures for effectively managing infection outbreaks are essential. In this…
Continue Reading
The integration of physics-based digital twins with data-driven artificial intelligence—termed “Big AI”—can advance truly personalised medicine. While digital twins offer individual ‘healthcasts,’ accuracy and interpretability, and AI delivers speed and flexibility, each has limitations….
Continue Reading
Existing prostate cancer monitoring methods, reliant on prostate-specific antigen (PSA) measurements in blood tests often fail to detect tumor growth. We develop a computational framework to reconstruct tumor growth from the PSA integrating physics-based…
Continue Reading
Digital Health Technologies represent a marked shift from current medical technologies in use, the approach to health and healthcare and stakeholders engaged in healthcare delivery. What the digitalized future of medicine will look like…
Continue Reading
Rare gynecological tumors (RGTs) present major clinical challenges due to their low incidence and heterogeneity. The lack of clear guidelines leads to suboptimal management and poor prognosis. Molecular tumor boards accelerate access to effective…
Continue Reading
Digital twins have been used in industries and is now gaining traction in healthcare, particularly in precision medicine. Discrete Event Simulation is a modelling methodology for simulating processes and workflows in healthcare. This paper…
Continue Reading
Pulmonary vein isolation (PVI), the standard-of-care for atrial fibrillation (AF), is effective even in some persistent AF (PsAF) patients despite atrial fibrosis proliferation, suggesting that PVI could not only be isolating triggers but diminishing…
Continue Reading
We developed a practical framework to construct digital twins for predicting and optimizing triple-negative breast cancer (TNBC) response to neoadjuvant chemotherapy (NAC). This study employed 105 TNBC patients from the ARTEMIS trial (NCT02276443, registered…
Continue Reading
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates genomic therapies for neurodegenerative diseases.Unlearn, founded in 2017, uses…
Continue Reading
